It is down-regulated in several malignancies and functions as a tumor suppressor in colorectal cancer, gallbladder cancer (33, 34), breast cancer (35) and esophageal squamous cell carcinoma (36), as well as suppresses bladder cancer development via inhibition of MALAT1 (32). This evidence concerns the gene MALAT1 and gallbladder cancer.